51Indexed trials
mesh condition
Epilepsies, Partial
Intelligence
Epilepsies, Partial intelligence: 51 indexed trials, 10 recruiting studies, 34 sponsors across 55 countries.
10Recruiting
34Sponsors
55Countries
Leading sponsors
UCB Pharma50 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.40 recruiting
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.40 recruiting
National Institute of Neurological Disorders and Stroke (NINDS)31 recruiting
Xenon Pharmaceuticals Inc.21 recruiting
UCB Pharma GmbH20 recruiting
Great Ormond Street Hospital for Children NHS Foundation Trust21 recruiting
Supernus Pharmaceuticals, Inc.21 recruiting
Mid-Atlantic Epilepsy and Sleep Center, LLC20 recruiting
Cyberonics, Inc.10 recruiting
Hospices Civils de Lyon10 recruiting
Comenius University11 recruiting
Geographic activity
United States23trials
France10trials
Germany10trials
United Kingdom8trials
Poland7trials
Spain7trials
Italy7trials
Czechia6trials
Bulgaria5trials
Mexico5trials
Belgium5trials
Hungary5trials
Leading interventions
Levetiracetam4trials
topiramate3trials
XEN11012trials
pregabalin2trials
Lamotrigine2trials
Topiramate2trials
Lacosamide2trials
BHV-70001trials
Additional electrodes into bilateral anterior, centromedian and pulvinar thalamic nuclei1trials
40 mg/day vormatrogine for 12 weeks1trials
CVL-8651trials
Buspirone1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.